These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18586055)

  • 21. C-type natriuretic peptide effects on cardiovascular nitric oxide system in spontaneously hypertensive rats.
    Caniffi C; Elesgaray R; Gironacci M; Arranz C; Costa MA
    Peptides; 2010 Jul; 31(7):1309-18. PubMed ID: 20363270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms involved in the regulation of mRNA for M2 muscarinic acetylcholine receptors and endothelial and neuronal NO synthases in rat atria.
    Ganzinelli S; Joensen L; Borda E; Bernabeo G; Sterin-Borda L
    Br J Pharmacol; 2007 May; 151(2):175-85. PubMed ID: 17384670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase A dependent signalling mediates anti-apoptotic effects of the atrial natriuretic peptide in ischemic livers.
    Kulhanek-Heinze S; Gerbes AL; Gerwig T; Vollmar AM; Kiemer AK
    J Hepatol; 2004 Sep; 41(3):414-20. PubMed ID: 15336444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C2238 atrial natriuretic peptide molecular variant is associated with endothelial damage and dysfunction through natriuretic peptide receptor C signaling.
    Sciarretta S; Marchitti S; Bianchi F; Moyes A; Barbato E; Di Castro S; Stanzione R; Cotugno M; Castello L; Calvieri C; Eberini I; Sadoshima J; Hobbs AJ; Volpe M; Rubattu S
    Circ Res; 2013 May; 112(10):1355-64. PubMed ID: 23529183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
    Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
    Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of nitric oxide/cyclic GMP and cyclic AMP in beta3 adrenoceptor-chronotropic response.
    Sterin-Borda L; Bernabeo G; Ganzinelli S; Joensen L; Borda E
    J Mol Cell Cardiol; 2006 Apr; 40(4):580-8. PubMed ID: 16510153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
    Mouawad R; Li Y; Anand-Srivastava MB
    Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelium negatively modulates the vascular relaxation induced by nitric oxide donor, due to uncoupling NO synthase.
    Bonaventura D; Lunardi CN; Rodrigues GJ; Neto MA; Vercesi JA; de Lima RG; da Silva RS; Bendhack LM
    J Inorg Biochem; 2009 Oct; 103(10):1366-74. PubMed ID: 19699534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial natriuretic peptide effect on NADPH-diaphorase in rat intestinal tract.
    González Bosc LV; Capani F; López-Costa JJ; Ortiz MC; Majowicz MP; Costa MA; Arranz CT; Balaszczuk AM; Pecci Saavedra J; Vidal NA
    Peptides; 1999; 20(5):615-21. PubMed ID: 10465514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats.
    Costa MD; Bosc LV; Majowicz MP; Vidal NA; Balaszczuk AM; Arranz CT
    Hypertension; 2000 May; 35(5):1119-23. PubMed ID: 10818074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of protein kinase B/Akt and endothelial nitric oxide synthase mediates agmatine-induced endothelium-dependent relaxation.
    Santhanam AV; Viswanathan S; Dikshit M
    Eur J Pharmacol; 2007 Oct; 572(2-3):189-96. PubMed ID: 17640632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Puerarin activates endothelial nitric oxide synthase through estrogen receptor-dependent PI3-kinase and calcium-dependent AMP-activated protein kinase.
    Hwang YP; Kim HG; Hien TT; Jeong MH; Jeong TC; Jeong HG
    Toxicol Appl Pharmacol; 2011 Nov; 257(1):48-58. PubMed ID: 21884717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise training upregulates nitric oxide synthases in the kidney of rats with chronic heart failure.
    Ito D; Ito O; Mori N; Cao P; Suda C; Muroya Y; Hao K; Shimokawa H; Kohzuki M
    Clin Exp Pharmacol Physiol; 2013 Sep; 40(9):617-25. PubMed ID: 23735016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial natriuretic peptides and urodilatin modulate proximal tubule Na(+)-ATPase activity through activation of the NPR-A/cGMP/PKG pathway.
    Vives D; Farage S; Motta R; Lopes AG; Caruso-Neves C
    Peptides; 2010 May; 31(5):903-8. PubMed ID: 20206222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension.
    Bae EH; Ma SK; Lee J; Kim SW
    Regul Pept; 2011 Oct; 170(1-3):31-7. PubMed ID: 21616096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
    Wei CL; Hon WM; Lee KH; Khoo HE
    Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of endothelial nitric oxide synthase: involvement of protein kinase G 1 beta, serine 116 phosphorylation and lipid structures.
    John TA; Ibe BO; Raj JU
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):148-58. PubMed ID: 17892503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation.
    Brunner F; Wölkart G
    Microvasc Res; 2001 Jan; 61(1):102-10. PubMed ID: 11162200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.